Agilent Technologies Inc
Change company Symbol lookup
Select an option...
A Agilent Technologies Inc
GS Goldman Sachs Group Inc
ONON On Holding AG
XNCR Xencor Inc
ALT Altimmune Inc
RZLT Rezolute Inc
BNKU MicroSectors? U.S. Big Banks Index 3X Leveraged ETNs
SGFY Signify Health Inc
FRC First Republic Bank
BACK IMAC Holdings Inc
Go

Health Care : Life Sciences Tools & Services | Large Cap Growth
Company profile

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.

Price
Delayed
$135.92
Day's Change
1.38 (1.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
136.28
Day's Low
135.22
Volume
(Light)

Today's volume of 506,622 shares is on pace to be much lighter than A's 10-day average volume of 1,603,255 shares.

506,622

Company Profile

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.

Valuation Ratios

Price/Earnings (TTM)
30.34x
Price/Sales (TTM)
5.74x
Price/Book (MRQ)
7.10x
Price/Cash Flow (TTM)
24.48x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

February 2023
Current Month
3.1M
Previous Month
3.0M
Percent of Float
1.05%
Days to Cover
2.0378 Days

Share Information

A is in a share class of common stock
Float
294.2M
Shares Outstanding
295.7M
Institutions Holding Shares
1,419
89.34%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Boon Hwee Koh
  • Michael R. McMullenPres.
  • Robert W. McMahonSr.VP
  • Michael TangSr.VP
  • Dominique P. GrauSr.VP

Address

Insider Trading

During the most recent quarter, 247K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.